本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

189.68
-7.2650-3.69%
成交量:176.82萬
成交額:3.38億
市值:406.54億
市盈率:-21.26
高:197.10
開:196.94
低:188.18
收:196.94
52周最高:224.31
52周最低:42.18
股本:2.14億
流通股本:1.85億
量比:1.09
換手率:0.96%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
淨資產收益率:-79.09%
總資產收益率:-30.12%
市淨率:15.60
市盈率(LYR):-31.88

資料載入中...

2023/08/02

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/02

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/02

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/01

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

重要事件披露

Form 8-K - Current report
2023/08/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/01

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/08/01

企業合併公告

Form 425 - Prospectuses and communications, business combinations
2023/07/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/16

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/06/10

重要事件披露

Form 8-K - Current report
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/03/07

重要事件披露

8-K - Current report
2023/02/27

重要事件披露

8-K - Current report